Cerenome Inc Com Par $0.0001 (New) Jan 2026 (CNSY:NASDAQ) closed at $1.64 on October 23, 2026, down 6.29% on the day. The stock trades 91.4% below its 52-week high of $19.00 and 10.1% above its 52-week low of $1.49. Over the past year, it lost 73.8%. Cerenome Inc Com Par $0.0001 (New) Jan 2026 is part of the Health Care sector.
In 178 trading sessions since February 10, 2026, CNSY closed higher on 69 days (39%). Its best day was April 9, 2026 (+23.66%) and its worst was March 31, 2026 (-23.81%). The stock moved 10% or more in a single session 14 times. It opened at least 5% above the previous day's high 1 time.
Plus Therapeutics, Inc. (NASDAQ: PSTV) is a clinical-stage healthcare company advancing an integrated approach to central nervous system ('CNS') cancers through precision therapeutics, molecular diagnostics and data-driven technologies. The Company's lead therapeutic platform, REYOBIQ¿ (rhenium Re186 obisbemeda), is being developed for the treatment of leptomeningeal metastases, recurrent glioblastoma and pediatric brain cancers. Its CNSide® cerebrospinal fluid assay platform is designed to provide diagnostic and disease monitoring information to support the management of patients with CNS cancers. Together with its growing data and artificial intelligence capabilities, Plus Therapeutics is building an integrated CNS oncology platform intended to improve clinical decision-making, accelerate therapeutic development and advance personalized care for patients with CNS cancers.
Find more stocks like CNSY with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.